Tumor collection and establishment of tumor-initiating cell cultures as antigen source for AV-GBM-1 dendritic cell vaccines for a phase II trial in patients with newly diagnosed glioblastoma

AV-GBM-1 - AiVita Biomedical

temozolomide - Generic mfg.

https://jitc.bmj.com//content/9/Suppl_2/A358

Christopher Duma 1; Daniela Bota 2; Frank Hsu 2; David Piccioni 3; Renato LaRocca 4; Santosh Kesari 5; Mehrdad Abedi 6; Jose Carrillo 5; Robert Aiken 7; Xiao-Tang Kong 2; Thomas Taylor 2; Candace Hsieh 8; Gabriel Nistor 8; Robert Dillman 8

Oct 1, 2021